NEA 16 GP, LLC 4
4 · Trevi Therapeutics, Inc. · Filed Apr 13, 2020
Insider Transaction Report
Form 4
New Enterprise Associates 16, L.P.
10% Owner
Transactions
- Exercise of In-Money
Call Option (right to buy)
2020-04-03−1,500,000→ 0 totalExercise: $0.00From: 2019-05-09Exp: 2022-05-06→ Common Stock (1,500,000 underlying) - Sale
Common Stock
2020-04-03$2.66/sh−564$1,500→ 5,937,998 total - Exercise of In-Money
Common Stock
2020-04-03$0.00/sh+1,500,000$1,500→ 5,938,562 total
Footnotes (3)
- [F1]The shares are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").The individual managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell, Peter W. Sonsini and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.
- [F2]On April 3, 2020, NEA 16 exercised a call option to purchase 1,500,000 shares of the Issuer's common stock ("Common Stock") for $0.001 per share. NEA 16 paid the exercise price through the forfeiture of 564 shares of Common Stock.
- [F3]The call option became exercisable upon the closing of the Issuer's initial public offering.